trimazosin has been researched along with Coronary Heart Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awan, NA; Hermanovich, J; Mason, DT; Skinner, P; Whitcomb, C | 1 |
| Barry, WH; Colucci, WS; Ganz, P; Gaspar, J; Horowitz, JD; Kern, MJ; Lorell, BH; Mudge, GH | 1 |
| Domenech, RJ; Macho, P | 1 |
3 other study(ies) available for trimazosin and Coronary Heart Disease
| Article | Year |
|---|---|
Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Disease; Drug Evaluation; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Piperazines; Plethysmography; Pulmonary Circulation; Quinazolines; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1979 |
Attenuation of coronary vascular resistance by selective alpha 1-adrenergic blockade in patients with coronary artery disease.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Flow Velocity; Blood Pressure; Cold Temperature; Coronary Circulation; Coronary Disease; Female; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Piperazines; Vascular Resistance; Vasodilator Agents | 1985 |
Effects of alpha-1 adrenergic blockade on regional flow in the ischemic heart.
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Circulation; Coronary Disease; Dogs; Piperazines; Vasodilator Agents | 1988 |